,
Welcome to City of Hope. As chairman of the Department of Medical Oncology & Therapeutics Research, I have the unique opportunity of working at City of Hope during a very exciting time. It has recently been marked by a number of exceptional physician recruits, including Arti Hurria M.D., Director of the newly founded Aging and Cancer Research Program. Dr. Hurria obtained her medical degree from Northwestern University, and after completing her residency at Beth-Israel Deaconess Hospital, completed her fellowship at Memorial Sloan Kettering. After serving as chief fellow, she received the American Society of Clinical Oncology (ASCO) Young Investigator Award and subsequently the ASCO Career Development Award. She continues to pursue research to interrelate aging and carcinogenesis in both preclinical and clinical models.
Alexandra M. Levine, M.D., Chief Medical Officer at City of Hope, is an internationally known expert in lymphoma, Hodgkin’s disease and AIDS-related malignancies. At City of Hope, Dr. Levine leads programs to improve standard of care in the fields of quality of service, patient safety and professional education. Dr. Levine was most recently named Distinguished Professor of Medicine and chair of the Division of Hematology at the Keck School of Medicine at University of Southern California. She has received over twenty major grants, primarily from the National Institutes of Health, and has done amazing work, including collaboration with Jonas Salk, M.D. in formulating an AIDS vaccine. In 1995, President Clinton appointed Dr. Levine to the Presidential Advisory Council on HIV/AIDS. She went on to chair the council’s research committee.
Karen Reckamp M.D., M.S., Assistant Professor in Hematology and Oncology, joined us last year from UCLA where she was instrumental in establishing a translational research program in thoracic oncology as part of the UCLA Specialized Program in Oncology Research and Education (SPORE). Additionally she is a prototype of a new type of medical oncologist at City of Hope having completed a masters degree in Clinical Investigation from the UCLA Department of Biomathematics. She holds numerous peer reviewed grants and is a past recipient of a career development award. Her efforts will be focused on expanding our translational lung cancer program.
To prospective fellows visiting this site, I am sure that you recognize the potential clinical and research opportunities that abound from these recent additions. It is important to realize that City of Hope, beyond this, boasts an extensive roster of clinicians and researchers that have put the institution at the forefront of medical oncology and hematology research for the past several decades. Please feel free to explore the site more fully and see what City of Hope has to offer for your career development.
Sincerely,
Robert Figlin, M.D., F.A.C.P.
Arthur and Rosalie Kaplan Professor of Medical Oncology
Chair, Department of Medical Oncology & Therapeutics Research
Associate Director for Clinical Research, Comprehensive Cancer Center